Castleark Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Castleark Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-204,140	Closed	-$4.11M	–	448
2018 Q1	$4.11M	Buy	+204,140	New	+$4.76M	0.13%	209
2015 Q4	–	Sell	-91,204	Closed	-$2.62M	–	435
2015 Q3	$2.62M	Sell	91,204 -69,484	-43%	-$2.97M	0.08%	236
2015 Q2	$7.19M	Sell	160,688 -56,325	-26%	-$2.12M	0.19%	151
2015 Q1	$7.5M	Buy	+217,013	New	+$5.91M	0.18%	155

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Castleark Management's DPLO Position: Q2 2018 in Review

Castleark Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 204,140 shares — an estimated $4.11M sold.

Castleark Management first reported a position in DPLO in Q1 2015 and held it in 4 quarters. The position peaked at $7.5M in Q1 2015. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

Castleark Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
Castleark Management sold 204,140 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $4.11M.
Castleark Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 4 quarters.
Castleark Management's DIPLOMAT PHARMACY, INC. position peaked at $7.5M in Q1 2015.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Castleark Management's 13F filing for Q2 2018, filed 15 Aug 2018.